QYD

Adalimumab Assay

Product code
QYD
Device name
Adalimumab Assay
Device class
Class 2
21 CFR
21 CFR 862.3115
Medical specialty
Clinical Toxicology
Marketing pathway
510(K)
510(k) clearances (last 3 years)
1
Summaries archived here
0 (direct download)
510(k) clearances (all years, FDA)
1 (all years; only the last 3 years are listed here)

FDA classification definition

An in vitro diagnostic device intended for the measurement of adalimumab, an anti-tumor necrosis factor alpha monoclonal antibody

Definition text from the FDA device classification database (U.S. federal government work, public domain).

510(k) clearances, last 3 years (1)

Last three years. Most recent: 2023-09-29.

NumberDecision dateApplicantDevice nameSummary
DEN2200232023-09-29Procisedx, Inc.Procise ADL
Official FDA classification page: QYD
Classification and pathway per current FDA publications. Data from openFDA (CC0).